Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor.

about

Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma.Co-precipitation molecules hemopexin and transferrin may be key molecules for fibrillogenesis in TTR V30M amyloidogenesis.

P2860

Q47127150-2C92BEAE-2BED-4A0E-93FE-13C9D4CC5439 Q47243785-89C97D6E-2E50-40E4-B238-33A24BD44C3E

P2860

Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor.

Item

http://www.wikidata.org/entity/Q38780920

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Analysis of a single-codon E74 ...... dermal growth factor receptor.

@en

type

Item

label

Analysis of a single-codon E74 ...... dermal growth factor receptor.

@en

prefLabel

Analysis of a single-codon E74 ...... dermal growth factor receptor.

@en

P1476

Analysis of a single-codon E74 ...... dermal growth factor receptor.

@en

P2093

Heisuke Saito

http://www.w3.org/2001/XMLSchema#string

Hiroo Nitanai

http://www.w3.org/2001/XMLSchema#string

Kazutaka Maeyama

http://www.w3.org/2001/XMLSchema#string

Kohei Yamauchi

http://www.w3.org/2001/XMLSchema#string

Masahito Ogasawara

http://www.w3.org/2001/XMLSchema#string

Mika Ohta

http://www.w3.org/2001/XMLSchema#string

Naoto Morikawa

http://www.w3.org/2001/XMLSchema#string

Ryosuke Chiba

http://www.w3.org/2001/XMLSchema#string

Satoshi Moriguchi

http://www.w3.org/2001/XMLSchema#string

Tamotsu Sugai

http://www.w3.org/2001/XMLSchema#string

P2860

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment

The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials.

Cell signaling by receptor tyrosine kinases

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

P2888

s00280-016-3021-y

P304

1019-1029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-016-3021-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yutaka Nakamura

P577

2016-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1004150159

http://www.w3.org/2001/XMLSchema#string

P698

27042857

http://www.w3.org/2001/XMLSchema#string

Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor.

about

P2860

P2860

Analysis of a single-codon E746 deletion in exon 19 of the epidermal growth factor receptor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698